RU2235786C2 - Способ подавления модуляции днк, набор - Google Patents

Способ подавления модуляции днк, набор Download PDF

Info

Publication number
RU2235786C2
RU2235786C2 RU2000121564/13A RU2000121564A RU2235786C2 RU 2235786 C2 RU2235786 C2 RU 2235786C2 RU 2000121564/13 A RU2000121564/13 A RU 2000121564/13A RU 2000121564 A RU2000121564 A RU 2000121564A RU 2235786 C2 RU2235786 C2 RU 2235786C2
Authority
RU
Russia
Prior art keywords
dna
mut
modulation
inhibition
chain
Prior art date
Application number
RU2000121564/13A
Other languages
English (en)
Russian (ru)
Other versions
RU2000121564A (ru
Inventor
Вольфганг В. ДЕППЕРТ (DE)
Вольфганг В. ДЕППЕРТ
Original Assignee
Вольфганг В. ДЕППЕРТ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вольфганг В. ДЕППЕРТ filed Critical Вольфганг В. ДЕППЕРТ
Publication of RU2000121564A publication Critical patent/RU2000121564A/ru
Application granted granted Critical
Publication of RU2235786C2 publication Critical patent/RU2235786C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
RU2000121564/13A 1998-01-26 1999-01-22 Способ подавления модуляции днк, набор RU2235786C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19802792.3 1998-01-26
DE19802792A DE19802792A1 (de) 1998-01-26 1998-01-26 Hemmung der durch mutiertes p53 verursachten Modulation von DNA

Publications (2)

Publication Number Publication Date
RU2000121564A RU2000121564A (ru) 2002-09-20
RU2235786C2 true RU2235786C2 (ru) 2004-09-10

Family

ID=7855657

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000121564/13A RU2235786C2 (ru) 1998-01-26 1999-01-22 Способ подавления модуляции днк, набор

Country Status (13)

Country Link
EP (1) EP1049810A2 (ko)
JP (1) JP2002507389A (ko)
KR (1) KR100413929B1 (ko)
CN (1) CN1289373A (ko)
AU (1) AU755775B2 (ko)
BR (1) BR9907725A (ko)
CA (1) CA2318313A1 (ko)
DE (2) DE19802792A1 (ko)
NO (1) NO20003762D0 (ko)
PL (1) PL342399A1 (ko)
RU (1) RU2235786C2 (ko)
SK (1) SK11052000A3 (ko)
WO (1) WO1999037803A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100348113C (zh) * 2005-05-14 2007-11-14 章建庆 一种食用籼草鱼的制作方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224784D0 (en) * 1992-11-26 1993-01-13 Univ Dundee Cellular protein
GB9521544D0 (en) * 1995-10-20 1995-12-20 Univ Dundee Activation of P53 protein and therapeutic applications thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MULLER et al. SPECIFIC BINDING OF MAR/SAR DNA-ELEMENTS ONCOGENE, 1996, vol.12. p.71941-1952. ABARZUA P et al. MICROINJECTION OF MONOCLONAL ANTIBODY PAB421 INTO HUMAN SW480 COLORECTAL CARCINOMA CELLS RESTORES THE TRANSCRIPTION ACTIVATION FUNCTION TO MUTANT P53 CANCER RESEARCH. - 1955, v.55, p.3490-3494. JANNOT C.B. et al. CHARACTERIZATION OF SCFV-421, A SINGLE-CHAIN ANTIBODY TARGETED TO P53 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. - 1997, vol. 230, no. 2, p.242-246. BODE et al. BIOLOGICAL SIGNIFICANCE OF UNWINDING CAPABILITY OF NUCLEAR MATRIX-ASSOCIATING DNAs SCIENCE. - 1992, р.195-197. *

Also Published As

Publication number Publication date
BR9907725A (pt) 2001-09-04
WO1999037803A3 (de) 1999-10-14
KR100413929B1 (ko) 2004-01-07
DE19802792A1 (de) 1999-07-29
AU2920099A (en) 1999-08-09
DE19980080D2 (de) 2001-03-29
NO20003762L (no) 2000-07-21
PL342399A1 (en) 2001-06-04
AU755775B2 (en) 2002-12-19
WO1999037803A2 (de) 1999-07-29
WO1999037803A9 (de) 1999-11-18
NO20003762D0 (no) 2000-07-21
CN1289373A (zh) 2001-03-28
JP2002507389A (ja) 2002-03-12
CA2318313A1 (en) 1999-07-29
EP1049810A2 (de) 2000-11-08
KR20010040407A (ko) 2001-05-15
SK11052000A3 (sk) 2001-05-10

Similar Documents

Publication Publication Date Title
Van Wijnen et al. Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1, and AP-1
US5525490A (en) Reverse two-hybrid method
Paonessa et al. Purification of a NF1‐like DNA‐binding protein from rat liver and cloning of the corresponding cDNA.
Dent et al. The DNA mobility shift assay
JP2002541762A5 (ko)
Diffley et al. Purification of a cellular, double-stranded DNA-binding protein required for initiation of adenovirus DNA replication by using a rapid filter-binding assay
Yeoman et al. Differences in chromatin proteins of growing and non-growing tissues
Ronai et al. Identification of ultraviolet-inducible proteins that bind to a TGACAACA sequence in the polyoma virus regulatory region
Bartell et al. Expression of the Rat Testis-specific Histone H1t Gene in Transgenic Mice: ONE KILOBASE OF 5′-FLANKING SEQUENCE MEDIATES CORRECT EXPRESSION OF A lacZ FUSION GENE
RU2235786C2 (ru) Способ подавления модуляции днк, набор
Nakao et al. c-Ha-ras down regulates the α-fetoprotein gene but not the albumin gene in human hepatoma cells
Vostrov et al. USF binds to the APBα sequence in the promoter of the amyloid β-protein precursor gene
Safer et al. DNA affinity labeling of adenovirus type 2 upstream promoter sequence-binding factors identifies two distinct proteins
Tabuchi et al. Underwinding of DNA on binding of yeast TFIID to the TATA element
Qasba et al. A single transcription factor binds to two divergent sequence elements with a common function in cardiac myosin light chain-2 promoter
Berger et al. An evolutionary switch in tissue-specific gene expression. Abundant expression of alpha 1-antitrypsin in the kidney of a wild mouse species.
US6132972A (en) Method for detecting nucleic acids through a triple-stranded DNA intermediate without denaturing
Čvoro et al. Intracellular localization of constitutive and inducible heat shock protein 70 in rat liver after in vivo heat stress
RU2201448C2 (ru) Способ модификации связывания p53 или его мутантной формы с геном-мишенью
WO1993008701A1 (en) C-myc dna binding partners, motifs, screening assays, and uses thereof
Lobov et al. Specific interaction of mouse major satellite with MAR-binding protein SAF-A
US20050070495A1 (en) Inhibition of DNA modulation caused by mutated p53
MXPA00007319A (en) INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
Plyte et al. Identification of a compact DNA-binding domain in the gene 5 protein of Pf1 bacteriophage
Xu et al. Repression of transcription initiation at 434 PR by 434 repressor: effects on transition of a closed to an open promoter complex

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20050123